Acute Kidney Injury Clinical Trials in Baltimore, Maryland

6 studies are recruiting for acute kidney injury in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

   This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to C…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Maryland Medical Center, Baltimore, Maryland

   Locations

   36 in total

   Run by

   SeaStar Medical

   See if you can join NCT05758077 on ClinicalTrials.gov

2. A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

   This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Research Site, Baltimore, Maryland

   Locations

   74 in total

   Run by

   AstraZeneca

   See if you can join NCT07215702 on ClinicalTrials.gov

3. A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

   The COPE-AKI study is a randomized, pragmatic, parallel-arm trial comparing a multimodal intervention to usual care on hospital-free days through 90 days of study follow up. The primary study hypothesis is that patients randomized to the intervention will have increased odds of more hospital-free d…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Maryland, Baltimore, Maryland

   Locations

   9 in total

   Run by

   University of Pittsburgh

   See if you can join NCT05805709 on ClinicalTrials.gov

4. CTSN Embolic Protection Trial

   This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

   Stage

   Not phased

   Ages

   60 and older

   Site

   Johns Hopkins Medicine, Baltimore, Maryland

   Locations

   28 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06027788 on ClinicalTrials.gov

5. Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels

   Acute normovolemic hemodilution (ANH) is performed as a blood conservation technique during surgical procedures with high risk for significant blood loss. It is done by taking out some of the patients blood before surgery actually begins and storing this blood inside of the operating room and givin…

   Stage

   Not phased

   Ages

   18 to 70

   Site

   University of Maryland Medical Center, Baltimore, Maryland

   Run by

   University of Maryland, Baltimore

   See if you can join NCT05349292 on ClinicalTrials.gov

6. Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support

   Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-m…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT06840210 on ClinicalTrials.gov